Protara Therapeutics News

Protara Therapeutics | EFFECT: Others

May 10 18:09

Protara Therapeutics | 424B3: Prospectus

May 10 04:50

Protara Therapeutics | EFFECT: Others

Nov 15, 2023 13:15

Protara Therapeutics | EFFECT: Others

Dec 21, 2020 13:16

Protara Therapeutics | 424B5: Prospectus

Sep 23, 2020 21:05

Protara Therapeutics | 424B5: Prospectus

Sep 23, 2020 21:02

Protara Therapeutics | 424B5: Prospectus

Sep 22, 2020 04:25

Protara Therapeutics | 424B5: Prospectus

Sep 22, 2020 04:24

Protara Therapeutics | EFFECT: Others

May 27, 2020 12:15

Protara Therapeutics | 424B3: Prospectus

Feb 12, 2020 05:16

Protara Therapeutics | EFFECT: Others

Feb 11, 2020 13:15

Protara Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jan 1, 2020 05:04

Protara Therapeutics | EFFECT: Others

Dec 20, 2019 13:15

Protara Therapeutics | 424B3: Prospectus

Dec 20, 2019 05:24

Protara Therapeutics | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Dec 19, 2019 06:45

Protara Therapeutics | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Dec 17, 2019 09:59

Protara Therapeutics | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Dec 5, 2019 10:43

Protara Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Nov 22, 2019 06:00

Protara Therapeutics | S-4: Registration of securities issued in business combination transactions

Nov 7, 2019 10:17

Protara Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Sep 25, 2019 04:15